Meta-analysis of radical resection rates and margin assessment in pancreatic cancer (Q38582990)

4 September 2017

0 references

Meta-analysis of radical resection rates and margin assessment in pancreatic cancer (English)

1 reference

4 September 2017

1 reference

1 reference

Manju D Chandrasegaram

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

James G Kench

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Neil D. Merrett

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

D Goldstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

J Simes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

V Gebski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

A J Gill

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

J S Samra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

A J Richardson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

A P Barbour

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

9 September 2015

1 reference

British Journal of Surgery

4 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1459-1472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

Redefining the R1 resection in pancreatic cancer.

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Pancreatic cancer surgery in the new millennium: better prediction of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Resection margins and R1 rates in pancreatic cancer--are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Resection margins in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Margin clearance and outcome in resected pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Survey of UK histopathologists' approach to the reporting of resection specimens for carcinomas of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Resection margin involvement and tumour origin in pancreatic head cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Definition of microscopic tumor clearance (r0) in pancreatic cancer resections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Neoadjuvant chemoradiation with tegafur in cancer of the pancreas: initial analysis of clinical tolerance and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

TNM staging for malignancies of the digestive tract: 2003 changes and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

Most Pancreatic Cancer Resections are R1 Resections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBJS.9892

21 January 2018

Identifiers

DOI

10.1002/BJS.9892

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26350029%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference